Diagnostic accuracy of surveillance tests for hepatocellular carcinoma in cirrhosis: a systematic review and network meta-analysis - Scorecard - MDSpire

Evaluating the Diagnostic Performance of Surveillance Methods for Hepatocellular Carcinoma in Cirrhotic Patients: A Systematic Review and Network Meta-Analysis

  • By

  • Gabriel Rogers

  • Efthymia Derezea

  • Libby Sadler

  • Hanyu Wang

  • Matthew E Cramp

  • Stephen D Ryder

  • Kelsey Watt

  • Penny Whiting

  • Morwenna Rogers

  • John Bell

  • Felicity Oppe

  • Ken Stein

  • Nicky J Welton

  • Hayley E Jones

  • July 17, 2026

Share

Clinical Scorecard: Evaluating the Diagnostic Performance of Surveillance Methods for Hepatocellular Carcinoma in Cirrhotic Patients: A Systematic Review and Network Meta-Analysis

At a Glance

CategoryDetail
ConditionHepatocellular carcinoma (HCC)
Key MechanismsSurveillance methods including imaging, serological biomarkers, and algorithms for early-stage tumor detection.
Target PopulationPeople with cirrhosis
Care SettingDiagnostic test accuracy evaluation

Key Highlights

  • Included 170 studies with 62,643 participants evaluating 115 index tests.
  • Ultrasound and alpha-fetoprotein show low sensitivity for very-early-stage HCC.
  • Contrast-enhanced MRI and CT demonstrate higher sensitivity across tumor stages.
  • Most studies assessed were at high risk of bias.
  • No genomic biomarkers showed significant improvements over conventional blood markers.

Guideline-Based Recommendations

Diagnosis

  • Routine ultrasound is recommended for HCC surveillance.
  • Alpha-fetoprotein testing is recommended alongside ultrasound by AASLD and JSH.

Management

  • Combination of ultrasound and alpha-fetoprotein may improve sensitivity.

Monitoring & Follow-up

  • Surveillance should aim to identify tumors at an earlier, more treatable stage.

Risks

  • High risk of bias in most studies may affect the reliability of findings.

Patient & Prescribing Data

Patients with cirrhosis at risk for HCC.

Need for better tests and stronger evidence-base for optimal surveillance strategies.

Clinical Best Practices

  • Utilize contrast-enhanced imaging for improved detection of early-stage HCC.
  • Consider combining ultrasound with serological markers for enhanced sensitivity.

Related Resources & Content

Original Source(s)

Related Content